Amiloride Inhibits Tissue-type Plasminogen Activator (t-PA) Release from Vascular Endothelium

• References

• 1 Kleyman TR, Cragoe Jr. EJ. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 1988; 105: 1-21
• 2 Howard MJ, Mullen MD, Insel PA. Amiloride interacts with renal a- and β-adrenergic receptors. Am J Physiol 1987; 253: F21-F25
• 3 D’Adamo MC, De Curtis A, Buczko W, Iacoviello L, Donati MB. The role of a-adrenergic receptors in the acute release of tissue-type plasminogen activator (t-PA) in a model of vascular perfusion in rats. Thromb Haemost 1993; 69: 544
• 4 Vassalli J-D, Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987; 214: 187-191
• 5 Iacoviello L, De Curtis A, Amore C, D’Adamo MC, Buczko W, de Gaetano G, Donati MB. Effect of aspirin on Ihe fibrinolytic response in perfused rathindquarters. Eur J Pharmacol 1992; 229: 39-44
• 6 Verheijen JH, Mullaart E, Chang GT G, Kluft C, Wijngaards G. A simple, sensitive spectrofotometric assay lor extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemosis 1982; 48: 266-269
• 7 Lesburg C, Li S, Crague Jr EJ, Deth RC. Influence of amiloride derivatives on alpha-1 adrenergic receptor-induced contractions of the rabbit aorta. J Pharmacol Exp Ther 1990; 253: 530-536